Patent ID: 6329357
Filing Date: 2001-12-11
Classification: A61K,C07C

Abstract:
A method for treatment of diseases connected with or caused by vitamin D.sub.3 deficiency by providing a subject in need of such treatment a vitamin D.sub.3 analog selected from the group consisting of the analog GE, namely, 14-epi-1.alpha.,25(OH).sub.2 D.sub.3, analog GF, namely, 14-epi-1.alpha.,25(OH).sub.2 -pre-D.sub.3, analog HJ, namely, 1.alpha.,25(OH).sub.2 -3-epi-D.sub.3, analog HQ, namely, (22S)-1.alpha.,25(OH).sub.2 -22,23-diene-D3, analog HR, namely, (22R)-1.alpha.,25(OH).sub.2 -22,23-diene-D3, analog JR, namely, 1.alpha.,25(OH).sub.2 -7,8-cis-D3, analog JS, namely, 1.alpha.,25(OH).sub.2 -5,6-trans-7,8-cis-D.sub.3, analog JV, namely, (1S,3R,6S)-1,3,25-trihydroxy-9,10-secocholesta-5(10),6,7-triene and analog JW, namely, (1S,3R,6R)-1,3,25-trihydroxy-9,10-secocholesta-5(10),6,7-triene.